본문 바로가기
KERD
논문KCI 등재

야맹증을 주소로 한 Pantothenate Kinase-Associated Neurodegeneration (PKAN) 1예

A Case of Retinal Pigmentary Degeneration in PKAN

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류안과학

초록

목적: PKAN (Pantothenate Kinase-Associated Neurodegeneration)은 매우 드물게 보고되고 있는 철 대사 장애로 인한 신경퇴행성질환으로, 저자들은 PKAN 1예를 경험하였기에 보고하고자 한다. 증례요약: 6세 여아가 야맹과 발달지연 및 보행장애를 주소로 내원하였다. 신경학적 검사상 내족지 보행, 근육긴장이상, 경직, 구음장애를 보였으며, 안저 검사상 망막색소변성 소견을 보였고, 망막전위도 검사에서 막대세포 및 원뿔세포 반응 저하가 관찰되었다. 뇌 자기공명영상촬영에서 바닥핵에 철 침착 소견을 보여(eye of the tiger sign), 유전학적 검사를 시행하여 PKAN으로 진단하였다. 결론: 안저검사상 망막색소변성이 관찰되며, 신경학적 검사상 이상소견 및 발달장애 소견이 보일 때, PKAN을 감별진단으로 염두에두어야 할 것으로 생각한다.

Abstract

Purpose: Pantothenate kinase-associated neurodegeneration (PKAN), also known as neurodegeneration with brain iron accumulation is an extremely rare degenerative disease. The present study reports a case of retinal pigmentary changes in PKAN. Case summary: A 6-year-old girl presented with night blindness and developmental delay. Neurologic examination revealed toe gait and dystonia. Ocular examination showed retinal pigmentary change in the entire retina without optic atrophy. Brain magnetic resonance imaging showed iron deposits in the basal ganglia, the so-called “eye of the tiger” sign. Genetic tests confirmed a mutation in the gene encoding pantothenate kinase 2. Electroretinography demonstrated severe loss of rod and cone responses, prominently reduced in the rod response. The patient was diagnosed with PKAN and pharmacologic treatment started. Conclusions: In the case of systemic neurological abnormalities with pigmentary retinal change, PKAN should be considered as a differential diagnosis.

참고문헌 (19)

  1. Rock CO, "Jackowski S. Pantothenate kinase regulation of the intracellular concentration of coenzyme A", J Biol Chem, 275, pp.1377~1383 (2000)
  2. Hayflick SJ, "Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome", N Engl J Med, 348, pp.33~40 (2003)
  3. Koeppen AH, "Iron in the Hallervorden-Spatz syndrome", Pediatr Neurol, 25, pp.148~155 (2001)
  4. Kuo YM, "Deficiency of pantothenate kinase 2 (Pank2) in mice leads to retinal degeneration and azoospermia", Hum Mol Genet, 14, pp.49~57 (2005)
  5. Egan RA, "Neuro-ophthalmologic and electroretinographic findings in pantothenate kinase-associated neurodegeneration (formerly Hallervorden-Spatz syndrome)", Am J Ophthalmol, 140, pp.267~274 (2005)
  6. Gordon N, "Pantothenate kinase-associated neurodegeneration (Hallervorden-Spatz syndrome)", Eur J Paediatr Neurol, 6, pp.243~247 (2002)
  7. Valentino P, "Genetic heterogeneity in patients with pantothenate kinase-associated neurodegeneration and classic magnetic resonance imaging eye-of-the-tiger pattern", Mov Disord, 21, pp.252~254 (2006)
  8. Zhou B, "A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome", Nat Genet, 28, pp.345~349 (2001)
  9. Johnson MA, "Mitochondrial localization of human PANK2 and hypotheses of secondary iron accumulation in pantothenate kinase-associated neurodegeneration", Ann N Y Acad Sci, 1012, pp.282~298 (2004)
  10. Hayflick SJ, "Cranial MRI changes may precede symptoms in Hallervorden-Spatz syndrome", Pediatr Neurol, 25, pp.166~169 (2001)
  11. Hayflick SJ., "Unraveling the Hallervorden-Spatz syndrome: pantothenate kinase-associated neurodegeneration is the name", Curr Opin Pediatr, 15, pp.572~577 (2003)
  12. Feliciani M, "Early clinical and imaging (high-field MRI) diagnosis of Hallervorden-Spatz disease", Neuroradiology, 36, pp.247~248 (1994)
  13. Ponka P., "Hereditary causes of disturbed iron homeostasis in the central nervous system", Ann N Y Acad Sci, 1012, pp.267~281 (2004)
  14. Gregory A, "Clinical and genetic delineation of neurodegeneration with brain iron accumulation", J Med Genet, 46, pp.73~80 (2009)
  15. Tripathi RC, "Clinicopathologic correlation and pathogenesis of ocular and central nervous system manifestations in Hallervorden-Spatz syndrome", Acta Neuropathol, 83, pp.113~119 (1992)
  16. He X, "Iron homeostasis and toxicity in retinal degeneration", Prog Retin Eye Res, 26, pp.649~673 (2007)
  17. Battistella PA, "Optic atrophy as the first symptom in Hallervorden-Spatz syndrome", Childs Nerv Syst, 14, pp.135~138 (1998)
  18. Newell FW, "Pigmentary degeneration of the retina in the Hallevorden-Spatz syndrome", Am J Ophthalmol, 88, pp.467~471 (1979)
  19. Sharma YR, "Retinitis pigmentosa and allied disorders", JK Sci, 6, pp.115~120 (2004)

관련 논문AI추천

이 간행물의 다른 논문 (24건)